Fig. 3From: P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signalingImages of the most common OC after 180 days of DMBA induction. The left ovaries of animals in the OC group presented a solid mass with necrotic spots (a and c). The left ovary of an animal treated with P-MAPA displayed a large cyst with serous secretions (b and f). CIS-treated (c and g) and P-MAPA+CIS-treated (d and h) animals presented a soft and mobile OC tissue with few adhesions. Right ovaries were sham-operated controls. i Abdominal cavity was opened to show an untreated neoplasm (white arrowhead). j A number of peritoneal implants (yellow arrowhead) with complex abdominal adhesions appeared in some untreated animals. k Left OC (black arrowhead) of a treated animal after the combination of P-MAPA and CIS. l Kaplan-Meier Curve showing animal survival rates (%) following the treatments (log-rank test p = 0.031; * shows significant differences from the OC group)Back to article page